2022 | Association between Genetic Polymorphisms and Bleeding in Patients on Direct Oral Anticoagulants | 곽혜선; 박준범; 송태진; 이정 | Article |
2023 | Association between genetic polymorphisms in fibrinogen genes and bleeding risk in patients treated with direct oral anticoagulants | 곽혜선; 박준범; 송태진; 이정 | Article |
2019 | Association between HNF4A mutations and bleeding complications in patients with stable international normalized ratio | 곽혜선 | Article |
2019 | Association between VEGFA gene polymorphisms and bleeding complications in patients maintaining therapeutic international normalized ratio | 곽혜선 | Article |
2023 | Construction of a risk scoring system using clinical factors and <i>RYR2</i> polymorphisms for bleeding complications in patients on direct oral anticoagulants | 곽혜선; 박준범; 송태진; 이정 | Article |
2020 | Efficacy and safety of clopidogrel versus prasugrel and ticagrelor for coronary artery disease treatment in patients with CYP2C19 LoF alleles: a systemic review and meta-analysis | 곽혜선; 성종미 | Review |
2019 | Genetic variations in the transcription factors GATA4 and GATA6 and bleeding complications in patients receiving warfarin therapy | 곽혜선 | Article |
2023 | Oral Anticoagulation Therapy in Atrial Fibrillation Patients with Advanced Chronic Kidney Disease: CODE-AF Registry | 박준범 | Article |
2023 | Standardized <i>in vitro</i> bleeding tests in a non-coated novel hybrid prosthesis for frozen elephant trunk demonstrates minimal oozing during full heparinization, supported by clinical data | 송석원 | Article |
2023 | Stroke-Specific Predictors of Major Bleeding in Anticoagulated Patients With Stroke and Atrial Fibrillation: A Nationwide Multicenter Registry-Based Study | 송태진 | Article |
2020 | Transcatheter arterial embolization for advanced gastric cancer bleeding A single-center experience with 58 patients | 김민욱; 조수범 | Article |